STX17 and Duchenne muscular dystrophy: Expression levels of STX17 (GSE1007_GPL92_58350_at, GSE1007_GPL92_49260_at) and SNAP29 (GSE1007_GPL92_46617_at) were also reduced in DMD patients (Fig. 2b).